Dr. Celine Mascaux graduated as M.D. from Free University of Brussels (ULB), Belgium, in 1999. She achieved specializations in internal medicine and in medical oncology in 2005, and was awarded by an educational grant. Between 2003 and 2008, she was also a research fellow of the National Funds of Scientific Research (F.R.S.-FNRS) in Belgium and was working in the thoracic oncology laboratory in Jules Bordet Institute, Cancer Center of ULB in Brussels.
She obtained her Ph.D. in Medical Sciences in 2008. Dr. Mascaux’s research interest has mainly been lung cancer, both regarding biological and clinical aspects. Her most recent studies and her thesis work have focused on biology of lung carcinogenesis and on biomarkers (protein, messenger RNAs and microRNAs) for early diagnosis of lung cancer. She is author of more than 50 papers.
Her Ph.D. thesis work was awarded by the Prize Alvarenga de Piauhy 2008 of the Royal Belgian Academy of Medicine and by an honorary fellowship of the Belgian American Education Foundation. Since 2009, she also obtained a prize of best poster presentation of the annual meeting of the Belgian Association for Cancer Research (BACR), an European Respiratory Society (ERS) Lung Science Conference Travel Award, ERS Young Investigator Award Session oral presenter, a Specialized Program of Research Excellence (SPORE) Career Development Award and in 2010, a AACR-IASLC Scholar-in-Training Award, a Lung Cancer Biomarker Chemoprevention Consortium (LCBCC) Award and an ASCO Merit Award.
She received an International Association for the Study of Lung Cancer (IASLC) Fellowship Award in 2009 and a Louisiana Chapter National Lung Cancer Young Investigator Award in 2011 to work at the University of Colorado in Dr. Fred Hirsch’s lab. She is presently Assistant Research Professor at University of Colorado. Her research projects are focusing on the molecular biology of lung carcinogenesis and on biomarkers mainly for screening, early detection, and chemoprevention, but also for prognosis and prediction of response to treatment of lung caner.